secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K/A
Filed at:   2026-05-13T20:05:17+00:00
Accession:  0001493152-26-022708
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

iMDx signs specimen collection agreement with Quest for GraftAssureCore test
----------------------------------------------------------------------------

- Entered Specimen Collection Agreement with Quest Diagnostics for services supporting GraftAssureCoreTM test.
- GraftAssureCore is a blood test measuring donor-derived cell-free DNA (dd-cfDNA) via PCR platform.
- Agreement covers specimen collection-related services to commercialize the test.
- No financial terms or duration of the agreement disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226022708/0001493152-26-022708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226022708/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-022708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer